neurology
Multiple sclerosis

Home infusions of natalizumab safe and feasible

Home infusions of natalizumab for relapsing-remitting MS are feasible, more convenient and less expensive than usual administration of the monoclonal antibody in the clinic, researchers say. A South Australian pilot study, randomised 37 adults on natalizumab for RRMS to home infusion delivered by nurses or usual clinic-based care for three infusions then crossed them over ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic